Investigation of TSRP reverses imatinib resistance through the PI3K / Akt pathway in chronic myeloid leukemia. He Y, Ding J, Liu L, Chen J, et al. Ann Hematol 2024 Nov 25. doi: 10.1007/s00277-024-06099.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

He Y, Ding J, Liu L, Chen J, et al. Investigation of TSRP reverses imatinib resistance through the PI3K / Akt pathway in chronic myeloid leukemia. Ann Hematol 2024 Nov 25. doi: 10.1007/s00277-024-06099.
PMID: 39586883